2389 — Beijing Health (Holdings) Income Statement
0.000.00%
Last trade - 00:00
- HK$393.82m
- HK$131.82m
- HK$140.35m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 201 | 150 | 204 | 166 | 140 |
Cost of Revenue | |||||
Gross Profit | 63.4 | 32.8 | 47 | 46.5 | 38.5 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 653 | 305 | 230 | 224 | 186 |
Operating Profit | -452 | -155 | -26.7 | -57.8 | -45.4 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -480 | -201 | -46.6 | -103 | -68.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -476 | -200 | -40.2 | -98.8 | -61.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -422 | -185 | -39.4 | -97.7 | -61.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -422 | -185 | -39.4 | -97.7 | -61.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.032 | -0.023 | -0.009 | -0.016 | -0.01 |